How Biotech Crops Can Crash—and Still Never Fail
By Aniket Aga, Maywa Montenegro de Wit,
Scientific American
| 12. 27. 2021
The United Nations Food Systems Summit held last September was eclipsed by a powerful countermobilization effort led by farmers and scientists, as well as civil society groups allied with Indigenous communities and small-scale food producers across the world. These are the very people critical to achieving the summit’s stated goals of ending hunger and promoting sustainable agriculture. The scientists and advocates accused summit organizers of compromising on food security, democratic accountability, sustainability, and the human rights of producers and workers in favor of transnational agribusinesses.
Opposition to the summit had been mounting since July, when hundreds of grassroots organizations challenged the organizers for framing the problem of food systems in narrow, technocratic ways and offering “false solutions” such as biotechnological interventions instead of promoting more sustainable, just and people-first ways of farming. Also in July the Philippines approved commercial cultivation of Bt eggplant, a genetically modified (GM) food that produces a protein that kills eggplant fruit and shoot borers, and “Golden Rice” altered to produce beta-carotene, the precursor of vitamin A. The Philippines thus became the first country...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Emile Torres, Jacobin | 11.15.2025
Watching tech moguls throw caution to the wind in the AI arms race or equivocate on whether humanity ought to continue, it’s natural to wonder whether they care about human lives.
The earnest, in-depth answer to this question is just...